Spinal Muscular Atrophy (SMA) Treatment Market Size, Share & Industry Analysis, By Product (Nusinersen and Onasemnogen Abeparvovec), By Disease Type (Type 1 SMA, Type 2 SMA and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI100576

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Forecast Period	2026-2034
Historical Period	2021-2034
Unit	Value (USD million)
Segmentation	By Product Nusinersen Onasemnogen Abeparvovec
	By Disease Type Type 1 SMA Type 2 SMA Others
	By Distribution Channel Hospital Pharmacies Retail Pharmacies Others
	By Geography North America (U.S. and Canada) Europe (U.K., Germany, France, Italy, Spain, and Rest of Europe) Asia Pacific (Japan, China, India, Australia, and Rest of Asia Pacific) Rest of the World